Home › Obesitas › Texas › Houston
Obesitas klinische studies in Houston, TX
43 studies voor Obesitas zoeken deelnemers op locaties in en rond Houston (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
RekruterenFase 2
- Juno Research /ID# 282413, Houston
- PlanIt Research /ID# 282204, Houston
- JCCT - Juno Bellaire /ID# 282263, Bellaire · 7 mijl verwijderd
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RekruterenFase 2
- Cardiovascular Specialists of Willowbrook, Houston
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
RekruterenFase 3
- PlanIt Research, PLLC, Houston
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
RekruterenFase 3
- DM Clinical, Houston
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
RekruterenFase 3
- Houston Research Institute, Houston
- The Endocrine Center, Houston
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RekruterenFase 3
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
RekruterenFase 3
- Research Site, Houston
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RekruterenFase 3
- McGovern Medical School, Houston
- Texas Childrens Hospital, Houston
- Dynamed Clinical Research, LP d/b/a DM Clinical Research, Houston
- en nog 1
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RekruterenFase 3
- Juno Research, Houston
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
RekruterenFase 3
- Juno Research, Houston
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
RekruterenFase 3
- Research Site, Houston
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RekruterenFase 3
- Biopharma Informatic, LLC, Houston
- Cardiovascular Specialists of Willowbrook, Houston
- PlanIt Research, PLLC, Houston
- en nog 2
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
RekruterenFase 3
- The University of Texas Health Science Center at Houston, Bellaire · 7 mijl verwijderd
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
RekruterenFase 3
- Care Access - Houston, Houston
- JCCT - Juno Bellaire Site, Bellaire · 7 mijl verwijderd
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
RekruterenFase 2
- PlanIt Research, PLLC, Houston
Semaglutide for Post-Smoking Cessation Weight Management
RekruterenFase 2Gezonde vrijwilligers welkom
- The University of Texas Health Science Center at Houston, Houston
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RekruterenFase 3
- AURORA-2 Clinical Site, Houston
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RekruterenFase 3
- East Texas Cardiology PA, Houston
- Biopharma Informatic, Houston
- Orion Medical, Houston
- en nog 3
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
RekruterenFase 3
- HRI ? Medical Center, LLC, Houston
- Juno Research, LLC, Houston
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
RekruterenFase 2
- Juno Research, Houston
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
RekruterenFase 3
- Elevate Clinical, Houston
- Houston Research Institute, Houston
- Bellaire Clinical Research, LLC, Bellaire · 7 mijl verwijderd
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
RekruterenFase 3
- Houston Pulm Med Res Network, Houston
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
RekruterenFase 3Gezonde vrijwilligers welkom
- ACCOMPLISH-2 Research Site, Houston
- ACCOMPLISH-2 Research Site, Houston
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
RekruterenFase 3
- Houston Pulm Med Res Network, Houston
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RekruterenFase 2
- PlanIt Research, PLLC, Houston
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
RekruterenFase 2
- Biopharma Informatic, LLC, Houston
- PlanIt Research, PLLC, Houston
- Research Physicians Network, LLC, Houston
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
RekruterenFase 4
- Center for Clinical Studies, Houston
- Bellaire Dermatology Associates, Bellaire · 7 mijl verwijderd
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
RekruterenFase 3
- JCCT- Juno Northwest Houston, Houston
- Biopharma Informatic, LLC, Houston
- Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 mijl verwijderd
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
RekruterenFase 3
- Kailera Clinical Site, Bellaire · 7 mijl verwijderd
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
RekruterenFase 3
- JCCT- Juno Northwest Houston, Houston
- Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 mijl verwijderd
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RekruterenFase 3
- Biopharma Informatic, LLC, Houston
- Research Physicians Network, LLC, Houston
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
RekruterenFase 3
- Research Site, Houston
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
RekruterenFase 2
- Baylor Texas Children's Hospital, Houston
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RekruterenFase 3
- East Texas Cardiology PA, Houston
- Victorium Clinical Research, Houston
- Main Heart Clinic, Houston
- en nog 1
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
RekruterenFase 3
- ACCOMPLISH-1 Research Site, Houston
- ACCOMPLISH-1 Research Site, Houston
PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents
RekruterenGezonde vrijwilligers welkom
- Children's Nutrition Research Center, Houston
Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
RekruterenGezonde vrijwilligers welkomVermeldt vergoeding voor deelnemers
- USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston
Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Lilli Health, Houston
Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery
Rekruteren
- M D Anderson Cancer Center, Houston
Incretin Microdosing for Cardiometabolic Health in People With HIV
RekruterenFase 2
- The University of Texas Health Science Center at Houston, Houston
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
RekruterenFase 2
- Baylor College of Medicine, Houston
RESET System Pivotal Trial (Rev F)
Rekruteren
- Baylor College of Medicine, Houston
Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity
Rekruteren
- Houston Methodist Hospital, Houston
Obesitas studies in andere steden
- Chicago, IL41 studies
- New York City, NY40 studies
- San Antonio, TX40 studies
- Washington, DC33 studies
- Orlando, FL31 studies
- Dallas, TX30 studies
- Boston, MA28 studies
- Las Vegas, NV27 studies
- Miami, FL27 studies
- Baltimore, MD25 studies
- Jacksonville, FL25 studies
- St. Louis, MO25 studies
Andere studies in Houston
- Niet-kleincellige longkanker145 studies
- Borstkanker126 studies
- Kanker (alle vormen)121 studies
- Metastatische kanker104 studies
- Colorectale kanker102 studies
- Eierstokkanker89 studies
- Acute myeloïde leukemie85 studies
- Longkanker78 studies
- Prostaatkanker76 studies
- Endometriumkanker68 studies
- Aldermeesklierkanker61 studies
- Melanoom59 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.